Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10–20-year longitudinal cohort study in southern Thailand

Pitchaya Satitpatanapan 1 , Somchit Jaruratanasirikul 1 ,  and Hutcha Sriplung 2
  • 1 Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
  • 2 Epidemiology Unit, Faculty of Medicine,, Prince of Songkla University, Hat Yai, Thailand
Pitchaya Satitpatanapan
  • Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Somchit Jaruratanasirikul
  • Corresponding author
  • Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand
  • Email
  • Search for other articles:
  • degruyter.comGoogle Scholar
and Hutcha Sriplung
  • Epidemiology Unit, Faculty of Medicine,, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand
  • Search for other articles:
  • degruyter.comGoogle Scholar

Abstract

Background

In 2011, we described 64 girls diagnosed with central precocious puberty (CPP) during 1995–2009. In 2019, the former CPP patients were 16–30 years of age and had been followed-up for 6–20 years after cessation of gonadotropin-releasing hormone analog (GnRHa) treatment.

Objectives

To determine the menstrual cycle, reproductive function, and long-term sequelae of the former GnRHa-treated and untreated CPP patients.

Methods

Sixty-seven former CPP women diagnosed during January 1995 to December 2010 were evaluated in 2019 for current menstrual cycle and pregnancy rate and for general health status, weight, height, blood pressure, and metabolic profiles of glucose, lipids, insulin, and testosterone.

Results

In 2019, the former CPP women averaged 20.7 ± 2.7 years of age (range: 16.5–30). Eighty-three percent had a regular menstrual cycle. Of the 14 married women, six (43%) were fertile with 1–2 children. The untreated women had a significantly higher rate of obesity (BMI >25 kg/m2) than the GnRHa-treated women (72.1% vs. 36.6%, p < 0.01). Two women (3%) had polycystic ovary syndrome (PCOS). Fasting plasma glucose, serum high-density lipoprotein cholesterol (HDL-C), and testosterone levels were normal and similar between the GnRHa-treated and untreated participants. The serum insulin, cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL-C), and homeostasis model assessment-insulin resistance (HOMA-IR) levels were higher in the untreated group than the GnRHa-treated group, but without significant differences.

Conclusions

At a 10–20-year follow-up, our former CPP patients had regular menstruation, normal reproductive function, and normal metabolic outcomes. The low prevalence of PCOS of 3% suggests that CPP is not a risk factor for PCOS, at least during early adulthood.

  • 1.

    Brito, VN, Spinola-Castro, AM, Kochi, C, Kopacek, C, Silva, PC, Guerra-Júnior, G. Central precocious puberty: revisiting the diagnosis and therapeutic management. Arch Endocrinol Metab 2016;60:163–72. https://doi.org/10.1590/2359-3997000000144.

    • Crossref
    • PubMed
    • Export Citation
  • 2.

    Carel, JC, Eugster, EA, Rogol, A, Ghizzoni, L, Palmert, MR. ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–62. https://doi.org/10.1542/peds.2008-1783.

    • Crossref
    • PubMed
    • Export Citation
  • 3.

    Jaruratanasirikul, S, Thaiwong, M. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand. J Pediatr Endocrinol Metab 2011;24:519–23. https://doi.org/10.1515/jpem.2011.006.

    • PubMed
    • Export Citation
  • 4.

    Nutrition Division. Department of Health, Ministry of Public Health, Bangkok, Thailand. National growth references for children under 20 years of age; 1999.

  • 5.

    Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–5. https://doi.org/10.1136/adc.44.235.291.

    • Crossref
    • PubMed
    • Export Citation
  • 6.

    Greulich, WW, Pyle, SI. Radiologic atlas of skeletal development of the hand and wrist. Stanford: Stanford University Press; 1959.

  • 7.

    Bayley, N, Pinneau, S. Tables for predicting adult height from skeletal age. J Pediatr 1952;14:432–41. https://doi.org/10.1016/s0022-3476(52)80205-7.

  • 8.

    Amiri, M, Ramezani Tehrani, F, Nahidi, F, Bidhendi Yarandi, R, Behboudi-Gandevani, S, Azizi, F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol (Oxf) 2017;87:217–30. https://doi.org/10.1111/cen.13389.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Azziz, R, Carmina, E, Dewailly, D, Diamanti-Kandarakis, E, Escobar-Morreale, HF, Futterweit, W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237–45. https://doi.org/10.1210/jc.2006-0178.

    • Crossref
    • PubMed
    • Export Citation
  • 10.

    Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9. https://doi.org/10.1007/bf00280883.

    • Crossref
    • PubMed
    • Export Citation
  • 11.

    Jay, N, Mansfield, MJ, Blizzard, RM, Crowley, WFJr, Schoenfeld, D, Rhubin, L, et al. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 1992;75:890–4. https://doi.org/10.1210/jc.75.3.890.

    • PubMed
    • Export Citation
  • 12.

    Feuillan, PP, Jones, JV, Barnes, K, Oerter-Klein, K, Cutler, GBJr. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999;84:44–9. https://doi.org/10.1210/jcem.84.1.5409.

    • Crossref
    • PubMed
    • Export Citation
  • 13.

    Tanaka, T, Niimi, H, Matsuo, N, Fujieda, K, Tachibana, K, Ohyama, K, et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. J Clin Endocrinol Metab 2005;90:1371–6. https://doi.org/10.1210/jc.2004-1863.

    • Crossref
    • Export Citation
  • 14.

    A1, Cassio, Bal, MO, Orsini, LF, Balsamo, A, Sansavini, S, Gennari, M, et al. Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults. J Pediatr 2006;149:532–6. https://doi.org/10.1016/j.jpeds.2006.05.026.

    • Crossref
    • PubMed
    • Export Citation
  • 15.

    AM, Pasquino, Pucarelli, I, Accardo, F, Demiraj, V, Segni, M, Di Nardo, R. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab 2008;93:190–5. https://doi.org/10.1210/jc.2007-1216.

    • Crossref
    • PubMed
    • Export Citation
  • 16.

    Poomthavorn, P, Suphasit, R, Mahachoklertwattana, P. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment. Gynecol Endocrinol 2011;27:524–8. https://doi.org/10.3109/09513590.2010.507289.

    • Crossref
    • PubMed
    • Export Citation
  • 17.

    Guaraldi, F, Beccuti, G, Gori, D, Ghizzoni, L. Management of endocrine disease: long-term outcomes of the treatment of central precocious puberty. Eur J Endocrinol 2016;174:R79–87. https://doi.org/10.1530/eje-15-0590.

    • Crossref
    • PubMed
    • Export Citation
  • 18.

    Lazar, L, Lebenthal, Y, Yackobovitch-Gavan, M, Shalitin, S, de Vries, L, Phillip, M, et al. Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades. J Clin Endocrinol Metab 2015;100:1445–51. https://doi.org/10.1210/jc.2014-3748.

    • Crossref
    • PubMed
    • Export Citation
  • 19.

    Colmenares, A, Gunczler, P, Lanes, R. Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment. Int J Pediatr Endocrinol 2014;2014:5. https://doi.org/10.1186/1687-9856-2014-5.

    • Crossref
    • PubMed
    • Export Citation
  • 20.

    Magiakou, MA, Manousaki, D, Papadaki, M, Hadjidakis, D, Levidou, G, Vakaki, M, et al. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 2010;95:109–17. https://doi.org/10.1210/jc.2009-0793.

    • Crossref
    • PubMed
    • Export Citation
  • 21.

    Bronstein, J, Tawdekar, S, Liu, Y, Pawelczak, M, David, R, Shah, B. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol 2011;24:15–20. https://doi.org/10.1016/j.jpag.2010.06.003.

    • Crossref
    • PubMed
    • Export Citation
  • 22.

    Franceschi, R, Gaudino, R, Marcolongo, A, Gallo, MC, Rossi, L, Antoniazzi, F, et al. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty. Fertil Steril 2010;1:1185–91. https://doi.org/10.1016/j.fertnstert.2008.11.016.

  • 23.

    Rosenfield, RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics 2015;136:1154–65. https://doi.org/10.1542/peds.2015-1430.

    • Crossref
    • Export Citation
  • 24.

    Wolf, WM, Wattick, RA, Kinkade, ON, Olfert, MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health 2018;15:E2589. https://doi.org/10.3390/ijerph15112589.

  • 25.

    AM, Jensen, Brocks, V, Holm, K, Laursen, EM, Müller, J. Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues. J Pediatr 1998;132:105–8. https://doi.org/10.1016/s0022-3476(98)70493-7.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

The Journal of Pediatric Endocrinology and Metabolism (JPEM) is the only international journal dedicated exclusively to endocrinology in the neonatal, pediatric and adolescent age groups, and publishes the results of clinical investigations in pediatric endocrinology and basic research. JPEM publishes Review Articles, Original Research, Case Reports, Short Communications and Letters to the Editor.

Search